The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, W. | - |
dc.date.available | 2020-08-18T05:35:12Z | - |
dc.date.created | 2020-07-31 | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 2296-634X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/77999 | - |
dc.description.abstract | Ewing sarcoma (ES) is a rare, highly aggressive, bone, or soft tissue-associated tumor. Although this sarcoma often responds well to initial chemotherapy, 40% of the patients develop a lethal recurrence of the disease, with death recorded in 75–80% of patients with metastatic ES within 5 years, despite receiving high-dose chemotherapy. ES is genetically well-characterized, as indicated by the EWS-FLI1 fusion protein encoded as a result of chromosomal translocation in 80–90% of patients with ES, as well as in ES-related cancer cell lines. Recently, tyrosine kinases have been identified in the pathogenesis of ES. These tyrosine kinases, acting as oncoproteins, are associated with the clinical pathogenesis, metastasis, acquisition of self-renewal traits, and chemoresistance of ES, through the activation of various intracellular signaling pathways. This review describes the recent progress related to cellular and molecular functional roles of tyrosine kinases in the progression of ES. © Copyright © 2020 Jin. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Frontiers Media S.A. | - |
dc.relation.isPartOf | Frontiers in Cell and Developmental Biology | - |
dc.title | The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000555838600001 | - |
dc.identifier.doi | 10.3389/fcell.2020.00613 | - |
dc.identifier.bibliographicCitation | Frontiers in Cell and Developmental Biology, v.8 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85088428506 | - |
dc.citation.title | Frontiers in Cell and Developmental Biology | - |
dc.citation.volume | 8 | - |
dc.contributor.affiliatedAuthor | Jin, W. | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | acquisition of self-renewal traits | - |
dc.subject.keywordAuthor | aggressiveness | - |
dc.subject.keywordAuthor | chemoresistance | - |
dc.subject.keywordAuthor | clinical pathogenesis | - |
dc.subject.keywordAuthor | Ewing sarcoma | - |
dc.subject.keywordAuthor | therapeutic target | - |
dc.subject.keywordAuthor | tyrosine kinases | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.